“Bioethics of Intervention and the Case of Drugs Bevacizumab and Ranibizumab for Retinal Diseases”. Revista Iberoamericana de Bioética, no. 2 (October 11, 2016): 1–10. Accessed December 5, 2025. https://revistas.comillas.edu/bioetica-revista-iberoamericana/article/view/7346.